cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.13145/bacdive3937.20240510.9
title: Dermatophilus congolensis (van Saceghem 1915) Gordon 1964 emend. Nouioui et al. 2018

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive3938.20240510.9
title: Dermatophilus congolensis (van Saceghem 1915) Gordon 1964 emend. Nouioui et al. 2018

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive3939.20240510.9
title: Dermatophilus congolensis (van Saceghem 1915) Gordon 1964 emend. Nouioui et al. 2018

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive3940.20240916.9.1
title: Dermatophilus congolensis (van Saceghem 1915) Gordon 1964 emend. Nouioui et al. 2018

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive3941.20240916.9.1
title: Kineosphaera limosa Liu et al. 2002

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive3942.20240916.9.1
title: Austwickia chelonae (Masters et al. 1995) Hamada et al. 2011

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive3943.20240916.9.1
title: Mobilicoccus pelagius Hamada et al. 2011

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive3944.20240916.9.1
title: Piscicoccus intestinalis Hamada et al. 2011

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive3945.20240510.9
title: Desulfatibacillum sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive3946.20240916.9.1
title: Desulfatibacillum aliphaticivorans Cravo-Laureau et al. 2004

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.15468/dl.sv3jaq
title: Occurrence Download

description: A dataset containing 1475 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Country is China",
 "TaxonKey is Bombycilla japonica (Siebold, 1824)"
 ]
}

 The dataset includes 1475 records from 14 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0199452-240321170329656/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.23rytv
title: Occurrence Download

description: A dataset containing 127114 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Geometry POLYGON((-72.51251 -13.27203,-72.81464 -13.91807,-72.47955 -14.63142,-71.40839 -14.66331,-71.14197 -13.82741,-71.45233 -13.28807,-72.51251 -13.27203))",
 "HasGeospatialIssue is false"
 ]
}

 The dataset includes 127114 records from 170 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0018626-200221144449610/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.ykmhsu
title: Occurrence Download

description: A dataset containing 11 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Flexiseps tsaratananensis (Brygoo, 1981)"
 ]
}

 The dataset includes 11 records from 5 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0284412-210914110416597/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.2rkzes
title: Occurrence Download

description: A dataset containing 3825 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Watsonia meriana (L.) Mill."
 ]
}

 The dataset includes 3825 records from 120 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0034031-230810091245214/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.crz7ac
title: Occurrence Download

description: A dataset containing 61 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Atelopus laetissimus Ruiz-Carranza, Ardila-Robayo & Hernández-Camacho, 1994"
 ]
}

 The dataset includes 61 records from 8 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0299482-210914110416597/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.eplchk
title: Occurrence Download

description: A dataset containing 14575668 species occurrences available in GBIF matching the query:
{
 "Country" : [
 "is Brazil"
 ]
}

 The dataset includes 14575668 records from 2870 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0011351-200221144449610/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.6084/m9.figshare.29908748
title: Supplementary Material for: A Complement Factor B Mutation in a Chinese Family with Atypical Hemolytic Uremic Syndrome: a case report and systematic review

description: Atypical hemolytic uremic syndrome (aHUS) is a rare and potentially life-threatening condition, often linked to dysregulation of the complement system. In this study, a novel heterozygous CFB mutation was identified in both the index patient and her sister, who both developed aHUS following respiratory infections. While the index patient succumbed to the condition, her sister achieved remission following treatment with eculizumab. Interestingly, other family members carrying the mutation remained asymptomatic, illustrating intrafamilial variability. The findings of this study may have significant implications for genetic counseling and early risk stratification in patients with CFB-associated aHUS.
DOI: 10.6084/m9.figshare.29908748.v1
title: Supplementary Material for: A Complement Factor B Mutation in a Chinese Family with Atypical Hemolytic Uremic Syndrome: a case report and systematic review

description: Atypical hemolytic uremic syndrome (aHUS) is a rare and potentially life-threatening condition, often linked to dysregulation of the complement system. In this study, a novel heterozygous CFB mutation was identified in both the index patient and her sister, who both developed aHUS following respiratory infections. While the index patient succumbed to the condition, her sister achieved remission following treatment with eculizumab. Interestingly, other family members carrying the mutation remained asymptomatic, illustrating intrafamilial variability. The findings of this study may have significant implications for genetic counseling and early risk stratification in patients with CFB-associated aHUS.
DOI: 10.6084/m9.figshare.29908748.v2
title: Supplementary Material for: A Complement Factor B Mutation in a Chinese Family with Atypical Hemolytic Uremic Syndrome: a case report and systematic review

description: Atypical hemolytic uremic syndrome (aHUS) is a rare and potentially life-threatening condition, often linked to dysregulation of the complement system. In this study, a novel heterozygous CFB mutation was identified in both the index patient and her sister, who both developed aHUS following respiratory infections. While the index patient succumbed to the condition, her sister achieved remission following treatment with eculizumab. Interestingly, other family members carrying the mutation remained asymptomatic, illustrating intrafamilial variability. The findings of this study may have significant implications for genetic counseling and early risk stratification in patients with CFB-associated aHUS.
DOI: 10.6084/m9.figshare.30095680
title: Supplementary Material for: Impact of Preexisting Intracranial Aneurysm on Incidence and Risk of De Novo Aneurysm Formation in Autosomal Dominant Polycystic Kidney Disease -Observational Study-

description: Introduction
Autosomal dominant polycystic kidney disease (ADPKD) has an elevated prevalence of intracranial aneurysms compared to the general population. However, the risk of de novo aneurysm formation in these patients remains unclear, leading to a lack of consensus regarding whom and when to follow. Although the data from general population tend to be referred, this assumption needs caution because patients with ADPKD have different characteristics such as location tendency, aneurysm size at rupture, and gene mutation. Here, we investigate the incidence of de novo aneurysm in ADPKD patients to examine whether patients without intracranial aneurysms on initial imaging needs frequent follow-up. 
Methods
This is a retrospective cohort study conducted in two ADPKD referral centers in Japan. Consecutive samples of 2,117 adult patients with ADPKD from April 2003 to October 2024 were eligible. Of these, 850 patients without baseline brain imaging and 555 patients without follow-up brain imaging were excluded, leaving 712 patients included in this study. Patients were divided into two groups according to the presence of intracranial aneurysm on the initial image. The primary outcome was the incidence of de novo aneurysm formation during follow-up. Kaplan-Meier analysis and Cox proportional hazards models were used to estimate risk, adjusting for age, sex, hypertension, smoking history, and family history of subarachnoid hemorrhage or aneurysm.
Results
Of 712 patients, 181 had intracranial aneurysms on initial imaging (screening-positive) and 531 had none (screening-negative). The median age was 54 years (IQR, 45–62 years), and 398 (55.8%) were women. Over 4,580 person-years of follow-up, the overall incidence of de novo aneurysm formation was higher in the screening-positive group (1.2 per 100 person-years), than in the screening-negative group (0.26 per 100 person-years) (HR, 3.81; 95%CI, 1.50–9.67, p = 0.005). 
Conclusion
ADPKD patients without preexisting aneurysms on initial imaging are at relatively low risk of developing de novo aneurysms. Our findings help to determine the adequate follow-up timing and its target in patients with ADPKD. However, caution is warranted in generalizing these results because the study population had a higher median age and more advanced kidney disease.
DOI: 10.6084/m9.figshare.30095680.v1
title: Supplementary Material for: Impact of Preexisting Intracranial Aneurysm on Incidence and Risk of De Novo Aneurysm Formation in Autosomal Dominant Polycystic Kidney Disease -Observational Study-

description: Introduction
Autosomal dominant polycystic kidney disease (ADPKD) has an elevated prevalence of intracranial aneurysms compared to the general population. However, the risk of de novo aneurysm formation in these patients remains unclear, leading to a lack of consensus regarding whom and when to follow. Although the data from general population tend to be referred, this assumption needs caution because patients with ADPKD have different characteristics such as location tendency, aneurysm size at rupture, and gene mutation. Here, we investigate the incidence of de novo aneurysm in ADPKD patients to examine whether patients without intracranial aneurysms on initial imaging needs frequent follow-up. 
Methods
This is a retrospective cohort study conducted in two ADPKD referral centers in Japan. Consecutive samples of 2,117 adult patients with ADPKD from April 2003 to October 2024 were eligible. Of these, 850 patients without baseline brain imaging and 555 patients without follow-up brain imaging were excluded, leaving 712 patients included in this study. Patients were divided into two groups according to the presence of intracranial aneurysm on the initial image. The primary outcome was the incidence of de novo aneurysm formation during follow-up. Kaplan-Meier analysis and Cox proportional hazards models were used to estimate risk, adjusting for age, sex, hypertension, smoking history, and family history of subarachnoid hemorrhage or aneurysm.
Results
Of 712 patients, 181 had intracranial aneurysms on initial imaging (screening-positive) and 531 had none (screening-negative). The median age was 54 years (IQR, 45–62 years), and 398 (55.8%) were women. Over 4,580 person-years of follow-up, the overall incidence of de novo aneurysm formation was higher in the screening-positive group (1.2 per 100 person-years), than in the screening-negative group (0.26 per 100 person-years) (HR, 3.81; 95%CI, 1.50–9.67, p = 0.005). 
Conclusion
ADPKD patients without preexisting aneurysms on initial imaging are at relatively low risk of developing de novo aneurysms. Our findings help to determine the adequate follow-up timing and its target in patients with ADPKD. However, caution is warranted in generalizing these results because the study population had a higher median age and more advanced kidney disease.
DOI: 10.6084/m9.figshare.30095683
title: Supplementary Material for: Extracorporeal Blood Purification with the oXiris® Filter for Patients with Sepsis and Hyperinflammatory Conditions: The Asia-Pacific oXiris Expert Meeting 2024 Consensus Statements

description: Extracorporeal blood purification (EBP) is an emerging technique for reducing elevated levels of inflammatory mediators and/or endotoxins in critically ill patients with sepsis or other hyperinflammatory conditions. The oXiris filter combines endotoxin adsorption, cytokine adsorption, hemofiltration and anti-thrombosis, and an emerging body of evidence demonstrates its use in critical care patients with hyperinflammatory conditions and acute kidney injury (AKI). A group of Asia-Pacific experts convened to formulate consensus statements for the use of the oXiris filter based on a comprehensive review of publications. After evaluation using a Delphi methodology, 17 statements achieved consensus (three recommendations and 14 practice points). These offer guidance on the initiation, monitoring and evaluation of treatment with the oXiris filter in patients with sepsis, septic shock, severe COVID-19 or other hyperinflammatory states. We also recommend using the oXiris filter in patients undergoing cardiopulmonary bypass for cardiac surgery who are at risk for developing AKI. Other statements discuss modality, dosage, filter lifespan, anticoagulation and combining the oXiris filter set with other extracorporeal therapies. Taken together, our statements offer targeted guidance for clinicians on the use of the oXiris filter across different patient populations. Additionally, we highlight the limitations of the current evidence base and identify key areas requiring further research.
DOI: 10.6084/m9.figshare.30095683.v1
title: Supplementary Material for: Extracorporeal Blood Purification with the oXiris® Filter for Patients with Sepsis and Hyperinflammatory Conditions: The Asia-Pacific oXiris Expert Meeting 2024 Consensus Statements

description: Extracorporeal blood purification (EBP) is an emerging technique for reducing elevated levels of inflammatory mediators and/or endotoxins in critically ill patients with sepsis or other hyperinflammatory conditions. The oXiris filter combines endotoxin adsorption, cytokine adsorption, hemofiltration and anti-thrombosis, and an emerging body of evidence demonstrates its use in critical care patients with hyperinflammatory conditions and acute kidney injury (AKI). A group of Asia-Pacific experts convened to formulate consensus statements for the use of the oXiris filter based on a comprehensive review of publications. After evaluation using a Delphi methodology, 17 statements achieved consensus (three recommendations and 14 practice points). These offer guidance on the initiation, monitoring and evaluation of treatment with the oXiris filter in patients with sepsis, septic shock, severe COVID-19 or other hyperinflammatory states. We also recommend using the oXiris filter in patients undergoing cardiopulmonary bypass for cardiac surgery who are at risk for developing AKI. Other statements discuss modality, dosage, filter lifespan, anticoagulation and combining the oXiris filter set with other extracorporeal therapies. Taken together, our statements offer targeted guidance for clinicians on the use of the oXiris filter across different patient populations. Additionally, we highlight the limitations of the current evidence base and identify key areas requiring further research.
DOI: 10.6084/m9.figshare.30095686
title: Supplementary Material for: Association between textbook outcomes of liver surgery (TOLS) and overall survival in gallbladder cancer patients treated with curative-intent resection: A multicenter study

description: Background
This study investigated the relationship between textbook outcomes of liver surgery (TOLS) and overall survival (OS) in patients who underwent curative-intent resection of GBC.
Method
Patients with GBC who underwent curative-intent resection between 2014 and 2021 were selected from 16 hospitals. Patients were divided into either the TOLS group or the non-TOLS group according to whether TOLS were observed. Patients who died within 90 days of surgery were excluded prior to the survival analysis. Log-rank test was used to compare the difference in the OS rate between TOLS and non-TOLS groups. Univariate and multivariate analyses were performed using Cox regression analysis to identify factors independently associated with OS.
Results
A total of 913 patients were selected, 565 (61.9%) exhibited TOLS. The 5-year OS rate in the TOLS group was significantly higher than that in the non-TOLS group (45.4% vs. 21.9%; P&lt;0.001). Multivariate Cox regression analysis confirmed TOLS, TB level&gt; 54 µmol/ml, CEA level&gt; 5 µg/ml, CA19-9 level&gt; 37 U/L, poor differentiation, stages T2 and T3/4 according to the 8th edition AJCC T staging manual, N1 and N2 according to the 8th edition AJCC N staging manual, and adjuvant chemotherapy as independent risk factors that affect OS after curative-intent resection of GBC.
Conclusion
Among patients who undergo curative-intent resection of GBC, approximately 61.9% experience TOLS. TOLS are not only the optimal short-term outcome but also associated with long-term survival.
DOI: 10.6084/m9.figshare.30095686.v1
title: Supplementary Material for: Association between textbook outcomes of liver surgery (TOLS) and overall survival in gallbladder cancer patients treated with curative-intent resection: A multicenter study

description: Background
This study investigated the relationship between textbook outcomes of liver surgery (TOLS) and overall survival (OS) in patients who underwent curative-intent resection of GBC.
Method
Patients with GBC who underwent curative-intent resection between 2014 and 2021 were selected from 16 hospitals. Patients were divided into either the TOLS group or the non-TOLS group according to whether TOLS were observed. Patients who died within 90 days of surgery were excluded prior to the survival analysis. Log-rank test was used to compare the difference in the OS rate between TOLS and non-TOLS groups. Univariate and multivariate analyses were performed using Cox regression analysis to identify factors independently associated with OS.
Results
A total of 913 patients were selected, 565 (61.9%) exhibited TOLS. The 5-year OS rate in the TOLS group was significantly higher than that in the non-TOLS group (45.4% vs. 21.9%; P&lt;0.001). Multivariate Cox regression analysis confirmed TOLS, TB level&gt; 54 µmol/ml, CEA level&gt; 5 µg/ml, CA19-9 level&gt; 37 U/L, poor differentiation, stages T2 and T3/4 according to the 8th edition AJCC T staging manual, N1 and N2 according to the 8th edition AJCC N staging manual, and adjuvant chemotherapy as independent risk factors that affect OS after curative-intent resection of GBC.
Conclusion
Among patients who undergo curative-intent resection of GBC, approximately 61.9% experience TOLS. TOLS are not only the optimal short-term outcome but also associated with long-term survival.
DOI: 10.6084/m9.figshare.30095689
title: Supplementary Material for: Delayed Diagnosis of Hepatitis C Infection–Results of a Nationwide U.S. Study

description: Background & Aims:
Universal hepatitis C virus (HCV) screening for the U.S. 1945-65 birth cohort was recommended in 2012 and effective direct-acting antivirals (DAA) for HCV became available in 2014. To examine their impact on the HCV care cascade, we investigated the proportion of and factors associated with delayed HCV diagnosis in a nationwide real-world cohort in the U.S.

Methods:
We retrospectively analyzed 69,989 adults with an HCV-related liver complication using the Merative™ Marketscan® Medicare Database (1/2007-12/2021). Delayed HCV diagnosis was defined as HCV diagnosis occurring within 2 years prior to or any time after occurrence of a liver complication (cirrhosis, hepatocellular carcinoma, or liver transplant).

Results:
The cohort mean age was 55.8 years, 65.9% were male, and the vast majority (60,628 or 86.6%) had delayed HCV diagnosis with 47.7% occurring within 6 months of the complication. The percentage of delayed HCV diagnosis decreased from 89.1% before 2015 to 75.1% in 2015-2021. In multivariable logistic regression analysis, higher Charlson Comorbidity Index (CCI) and complication diagnosis dates after 2015 were associated with lower odds of having a delayed diagnosis for HCV, while male sex, alcohol use, and mental health were associated with higher odds of having a delayed HCV diagnosis.

Conclusion:
Delayed HCV diagnosis occurred in almost 9 in 10 patients with chronic hepatitis C (CHC) and liver complications overall and in 3 out of 4 even after DAA availability during the 2015-2021 time period. Further efforts are needed to improve HCV screening and linkage to care.
DOI: 10.6084/m9.figshare.30095689.v1
title: Supplementary Material for: Delayed Diagnosis of Hepatitis C Infection–Results of a Nationwide U.S. Study

description: Background & Aims:
Universal hepatitis C virus (HCV) screening for the U.S. 1945-65 birth cohort was recommended in 2012 and effective direct-acting antivirals (DAA) for HCV became available in 2014. To examine their impact on the HCV care cascade, we investigated the proportion of and factors associated with delayed HCV diagnosis in a nationwide real-world cohort in the U.S.

Methods:
We retrospectively analyzed 69,989 adults with an HCV-related liver complication using the Merative™ Marketscan® Medicare Database (1/2007-12/2021). Delayed HCV diagnosis was defined as HCV diagnosis occurring within 2 years prior to or any time after occurrence of a liver complication (cirrhosis, hepatocellular carcinoma, or liver transplant).

Results:
The cohort mean age was 55.8 years, 65.9% were male, and the vast majority (60,628 or 86.6%) had delayed HCV diagnosis with 47.7% occurring within 6 months of the complication. The percentage of delayed HCV diagnosis decreased from 89.1% before 2015 to 75.1% in 2015-2021. In multivariable logistic regression analysis, higher Charlson Comorbidity Index (CCI) and complication diagnosis dates after 2015 were associated with lower odds of having a delayed diagnosis for HCV, while male sex, alcohol use, and mental health were associated with higher odds of having a delayed HCV diagnosis.

Conclusion:
Delayed HCV diagnosis occurred in almost 9 in 10 patients with chronic hepatitis C (CHC) and liver complications overall and in 3 out of 4 even after DAA availability during the 2015-2021 time period. Further efforts are needed to improve HCV screening and linkage to care.